Key Highlights
● The proposal would widen audits of Medicare Advantage plans.
● It is a proposal, not a final regulation, and applies industry-wide.
● UnitedHealth closed at its lowest level since April.
● Humana, Elevance Health and Centene fell again.
Health insurers extended their slide on Thursday, November 19, as investors kept reassessing a federal proposal to widen audits of Medicare Advantage plans, a regulatory change that would apply across the entire industry.
The proposal at the center
The Centers for Medicare & Medicaid Services, the federal agency that runs Medicare, has proposed widening its audits of Medicare Advantage, The measure was described as a "CRUSH" anti-fraud rule. It is a proposal, not a final regulation, and it applies to the industry as a whole rather than to any single company.
Medicare Advantage is the program through which private insurers offer Medicare coverage to older Americans, with the government paying the plans to provide benefits. Payments are adjusted based on how sick each plan's members are, and the government audits plans to check that the diagnoses behind those payments are documented properly. Broader audits could change how much money flows to plans across the program, which is why investors treat the proposal as a sector-wide issue.
A second day of heavy selling
The selling began in earnest on Wednesday, November 18, and carried into Thursday. UnitedHealth (NYSE:UNH) Group fell sharply again on Thursday after a steep drop the day before. It closed at its lowest level since April, and it was among the biggest decliners in the Dow Jones Industrial Average, alongside Nike (NYSE:NKE).
Other insurers also lost ground. Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) each fell again on Thursday after steep declines on Wednesday. Hospital operator Universal Health Services (NYSE:UHS) also dropped sharply, moving with the broader managed-care and health care selling tied to the CMS proposal.
UnitedHealth suffered another heavy loss.
Health care's rough session
The pressure on insurers weighed on the whole health care sector, which was among the weaker groups as the S&P 500 fell 147.80 points to 7,175.83 for a sixth straight loss. Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) also slipped as health care weakness dragged on the indexes.
There was one notable bright spot in the sector: Insmed (NASDAQ:INSM) surged after an unconfirmed media report said Sanofi (NASDAQ:SNY) is studying a possible Acquisition of the company; neither company commented.
Why the market reacts so strongly
Medicare Advantage has become a large part of the Business for several major insurers, so changes to how plans are paid or audited can have an outsized effect on expected earnings. Even a proposal that has not been finalized can prompt investors to revise their assumptions, because the potential impact stretches across future years.
The broader market mood amplified the move. The Dow fell 1,101.11 points to 49,097.06, closing below 50,000, and the VIX rose 3.88 points to 28.44. One market strategist said, "People just don't have much enthusiasm for this market, and rallies tend to bring out sellers instead of chasers."
What to watch
Investors will look for more detail on the scope and timing of the CMS proposal, including any comment period and how the final rule might differ from the draft. Insurers' own commentary on the potential financial impact will be closely followed, as will any response from industry groups. Because the proposal affects the entire Medicare Advantage market, developments are likely to move the group together rather than any single company in isolation.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...